In the News

Apr 22, 2011

Practice Management Networks Are Manufacturers’ Gateway to Oncology : The recent acquisition of US Oncology by McKesson highlights the rising importance of the distributor-led networks

Pharmaceutical Commerce

By Nicholas Basta

Jeff Forringer, President of IntrnisiQ, LLC was interviewed for this article.

Manufacturers looking at any market for a therapy, branded or generic, are dealing with a more complex interplay of market demand, reimbursement and regulatory compliance. The oncology market takes that complexity up exponentially, and not just because it’s a highly valued market seeing many new therapies being introduced and in the pipeline.

Read the full article.